Broadly neutralizing human anti-HIV antibody 2G12 is effective in protection against mucosal SHIV challenge even at low serum neutralizing titers.
Hessell AJ, Rakasz EG, Poignard P, Hangartner L, Landucci G, Forthal DN, Koff WC, Watkins DI, Burton DR. · 2009
Read Broadly neutralizing human anti-HIV antibody 2G12 is effective in protection against mucosal SHIV challenge even at low serum neutralizing titers. by Hessell AJ, Rakasz EG, Poignard P, Hangartner L, Landucci G, Forthal DN, Koff WC, Watkins DI, Burton DR. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc2674935.txt.
Description
Hessell and co-authors tested in 2009 whether a famous HIV-blocking antibody could protect monkeys at strikingly low blood levels. The antibody, 2G12, locks onto sugars on the virus surface and neutralizes many strains. Most such antibodies need high levels to protect, which had dimmed hopes for an antibody-based vaccine. Earlier hints suggested 2G12 might be an exception.
The team dosed five monkeys and exposed them to a monkey-human hybrid virus through the vagina, mimicking sexual transmission. At blood levels so low they barely registered, three monkeys were fully protected, with no sign of infection at all. One showed a delayed, smaller infection, and one was not protected. Comparisons with a rival antibody found no edge for 2G12 in reaching the vaginal surface or in calling in killer cells, leaving its unusual strength unexplained.
Catalog record
| CREATOR | Hessell AJ, Rakasz EG, Poignard P, Hangartner L, Landucci G, Forthal DN, Koff WC, Watkins DI, Burton DR. |
|---|---|
| YEAR | 2009 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 43 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |